Metabolic acidosis future or investigational therapies
 |
Resident Survival Guide |
| File:Physician Extender Algorithms.gif |
|
Metabolic acidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic acidosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Metabolic acidosis future or investigational therapies |
|
FDA on Metabolic acidosis future or investigational therapies |
|
CDC on Metabolic acidosis future or investigational therapies |
|
Metabolic acidosis future or investigational therapies in the news |
|
Blogs on Metabolic acidosis future or investigational therapies |
|
Risk calculators and risk factors for Metabolic acidosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Experimental Treatment:
Small animal studies of various models of shock and lactic acidosis demonstrated improved cardiac function, reduced mortality, and decreased generation of pro-inflammatory cytokines; human studies yet to be performed, so options include as follows:
- Dichloroacetate
- Administration of selective inhibitors Na+-H+ Exchanger 1 or amiloride analogues
- Administration of inhibitors of transient receptor potential vanilloid 1
- Administration of selective inhibitors acid sensing Ion channel la
- Administration of inhibitors of mitogen activated protein kinase